CIK 0001567264 · <br>Emerging growth company
INTENSITY THERAPEUTICS, INC.
Sign in to watch- Ticker
- INTS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461488089
- Phone
- 203-221-7381
- Business address
- 1 ENTERPRISE DRIVE, SUITE 430, SHELTON, CT, 06484
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-16 | Donovan Daniel Director | Grant or award · Stock Option (right to buy Common Stock) | +5,500 | 5,500 | ||
| 2026-07-16 | Wesolowski John M Principal Accounting Officer | Grant or award · Stock Option (right to buy Common Stock) | +11,000 | 11,000 | ||
| 2026-07-16 | Leahy Emer Director | Grant or award · Stock Option (right to buy Common Stock) | +5,500 | 5,500 | ||
| 2026-07-16 | Talamo Joseph Chief Financial Officer | Grant or award · Stock Option (right to buy Common Stock) | +34,000 | 34,000 | ||
| 2026-07-16 | GOLDBERG MARK A Director | Grant or award · Stock Option (right to buy Common Stock) | +5,500 | 5,500 | ||
| 2026-07-16 | BENDER LEWIS H President and CEO | Grant or award · Stock Option (right to buy Common Stock) | +78,000 | 78,000 | ||
| 2026-07-16 | DUBIN THOMAS I H Director | Grant or award · Stock Option (right to buy Common Stock) | +5,500 | 5,500 | ||
| 2026-06-30 | Wesolowski John M Principal Accounting Officer | Grant or award | +3,688 | $3.49 | $13K | 7,102 |
| 2026-06-30 | Talamo Joseph Chief Financial Officer | Grant or award | +1,093 | $3.49 | $4K | 2,239 |
| 2026-03-26 | BENDER LEWIS H President and CEO | Grant or award | +37,749 | $6.11 | $231K | 118,549 |
| 2025-12-31 | Wesolowski John M Principal Accounting Officer | Grant or award | +8,918 | $0.26 | $2K | 85,354 |
| 2025-12-31 | Talamo Joseph Chief Financial Officer | Grant or award | +14,482 | $0.26 | $4K | 28,661 |
| 2025-06-30 | Wesolowski John M Principal Accounting Officer | Grant or award | +69,745 | $0.26 | $18K | 76,436 |
| 2025-06-30 | Talamo Joseph Chief Financial Officer | Grant or award | +14,179 | $0.26 | $4K | 14,179 |
| 2025-05-02 | Wesolowski John M Principal Accounting Officer | Grant or award · Stock Option (right to buy Common Stock) | +100,000 | 100,000 | ||
| 2025-05-02 | DUBIN THOMAS I H Director | Grant or award · Stock Option (right to buy Common Stock) | +50,000 | 50,000 | ||
| 2025-05-02 | Donovan Daniel Director | Grant or award · Stock Option (right to buy Common Stock) | +50,000 | 50,000 | ||
| 2025-05-02 | GOLDBERG MARK A Director | Grant or award · Stock Option (right to buy Common Stock) | +50,000 | 50,000 | ||
| 2025-05-02 | Leahy Emer Director | Grant or award · Stock Option (right to buy Common Stock) | +50,000 | 50,000 | ||
| 2025-05-02 | Wesolowski John M Principal Accounting Officer | Grant or award · Stock Option (right to buy Common Stock) | +100,000 | 100,000 |
Page 1 of 2 · 35 trades